Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POuND OUT
NCT04621929Phase 2Completed
- Sponsor
- University of Florida
- Start
- Mar 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of phentermine and topiramate in Uric Acid Nephrolithiasis (2 arms), sponsored by University of Florida. Primary endpoint: Kidney Stone Size Determined by Non-contrast CAT Scan at 18 months. Started Mar 2021; status: completed.
02
Drugs
phenterminetopiramate
03
Conditions
Uric Acid Nephrolithiasis
Beyond the preview
Go deeper on NCT04621929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621929.